Page last updated: 2024-11-06

3,4-Methylenedioxyacetophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID76622
CHEMBL ID1380211
CHEBI ID167425
SCHEMBL ID137979

Synonyms (73)

Synonym
MLS000515804
smr000112277
1-(1,3-benzodioxol-5-yl)ethanone
CHEBI:167425
acetopiperone
8jg2oh2m57 ,
1-(1,3-benzodioxol-5-yl)ethan-1-one
unii-8jg2oh2m57
einecs 221-613-1
nsc 21866
ethanone, 1-(1,3-benzodioxol-5-yl)-
ai3-30572
3,4-methylenedioxyacetophenone
3',4'-(methylenedioxy)acetophenone
nsc-21866
3162-29-6
nsc21866
3',4'-(methylenedioxy)acetophenone, 98%
bmhmkwxyxfbwmi-uhfffaoysa-
inchi=1/c9h8o3/c1-6(10)7-2-3-8-9(4-7)12-5-11-8/h2-4h,5h2,1h3
5-acetyl-1,3-benzodioxole
M0874
AKOS000119406
1-benzo[1,3]dioxol-5-yl-ethanone
NCGC00246999-01
3',4'-methylenedioxyacetophenone
1-(1,3-benzodioxol-5-yl)-1-ethanone
3,4-(methylenedioxy)acetophenone
AE-508/40226031
1-(1,3-benzodioxol-5-yl)-ethanone
HMS2268E15
3,4-methylendioxyacetophenone
FT-0614104
1-(2h-1,3-benzodioxol-5-yl)ethan-1-one
FS-3660
AM20050569
1-(benzo[d][1,3]dioxol-5-yl)ethanone
F0001-0949
SCHEMBL137979
3,4-methylendioxy acetophenone
CHEMBL1380211
3,4-methylenedioxy-acetophenone
1-acetyl-3,4-methylenedioxybenzene
3',4'-methylenedioxy-acetophenone
3,4-methylenedioxy acetophenone
5 -acetyl-1,3-benzodioxole
1-(1,3-benzodioxol-5-yl)acetaldehyde
3', 4'-methylenedioxyacetophenone
acetopiperon
3,4-methylenedioxycetophenone
1-(1,3-benzodioxol-5-yl)ethanone #
3,4-methylen-dioxy-acetophenon
W-106888
3',4'-(methylenedioxy) acetophenone
STR03337
CS-W010839
mfcd00005831
DTXSID40185502
AC-9517
3 inverted exclamation mark ,4 inverted exclamation mark -(methylenedioxy)acetophenone
SY048504
F10428
1-acetyl-3,4-(methylenedioxy)benzene
acetophenone, 3',4'-(methylenedioxy)-
acetophenone, 3,4-methylenedioxy-
3,4-(methylenedioxy)phenyl methyl ketone
1-(benz(d)(1,3)dioxol-5-yl)ethanone
moskachan a
1-(benzodioxol-5-yl)ethanone
STL183268
1-(benzo[d][1,3]dioxol-5-yl)ethan-1-one
1-(1,3-dioxaindan-5-yl)ethan-1-one
EN300-20343
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzodioxoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency5.01190.044717.8581100.0000AID485294
USP1 protein, partialHomo sapiens (human)Potency0.03160.031637.5844354.8130AID743255
gemininHomo sapiens (human)Potency6.51310.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1113018Nematicidal activity against second-stage juveniles of Meloidogyne incognita (root-knot nematode) after 1 hr by inverted microscopic analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
AID1113017Nematicidal activity against second-stage juveniles of Meloidogyne incognita (root-knot nematode) after 1 day by inverted microscopic analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.62 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index38.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]